Evidence map›Paper›PMID 40170389›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus.

Gaukhar Mergenova, Alissa Davis, Susan L Rosenthal, Assel Terlikbayeva, Sholpan Primbetova, Meruyert Darisheva, Assel Bukharbayeva, Alfiya Y Denebayeva, Jack DeHovitz

Abstract read
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gaukhar MergenovaGlobal Health Research Center of Central Asia, Almaty, Kazakhstan.ORCID 0000-0003-4702-1944
Alissa DavisColumbia University School of Social Work, Columbia University, New York, NY, USA.ORCID 0000-0003-2084-9741
Susan L RosenthalDepartment of Pediatrics and Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center-New York (United States), New York, NY, USA.
Assel TerlikbayevaGlobal Health Research Center of Central Asia, Almaty, Kazakhstan.ORCID 0000-0002-4067-1998
Sholpan PrimbetovaGlobal Health Research Center of Central Asia, Almaty, Kazakhstan.ORCID 0000-0002-7633-7764
Meruyert DarishevaGlobal Health Research Center of Central Asia, Almaty, Kazakhstan.
Assel BukharbayevaDepartment of Epidemiology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Alfiya Y DenebayevaDepartment of Epidemiology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Jack DeHovitzState University of New York Downstate Health Sciences University, Brooklyn, NY, USA.ORCID 0000-0001-7307-0614

Funding

Research Training for Substance Use Mediated HIV Epidemic in Kazakhstan/Aging SupplementD43TW010046 · FIC · SUNY DOWNSTATE MEDICAL CENTER · PI Jack A DeHovitz, Zhamilya Nugmanova · 2016 to 2026
$3.4M
FIC NIH HHS D43 TW010046
6 · The paper itself

Abstract

BackgroundHuman immunodeficiency virus (HIV) cases are rising in Central Asia and Kazakhstan. People living with HIV (PLWH) in Kazakhstan are at heightened risk of severe COVID-19. We conducted a study to evaluate determinants of COVID-19 vaccine uptake among PLWH in Kazakhstan.MethodsIn this cross-sectional study, 196 PLWH were recruited from the Almaty City AIDS Center (July 2022-January 2023). We used logistic regression to evaluate how multilevel factors are associated with COVID-19 vaccine uptake among PLWH in Kazakhstan.ResultsCOVID-19 vaccine non-uptake was associated with higher HIV stigma scores (AOR = 1.08, 95%CI:1.02,1.16, P = 0.017), a lower level of education (AOR = 2.53, 95%CI: 1.04,6.17, P = 0.0412), and never receiving the flu vaccine (AOR = 15.64, 95%CI:3.66,66.89, P = 0.0002). Participants with at least mild anxiety symptoms (AOR = 0.15, 95%CI:0.03,0.64, P = 0.0107) and a positive attitude towards vaccination (AOR = 0.79, 95%CI: 0.73,0.86, P < 0.0001) were less likely to remain unvaccinated against COVID-19.ConclusionsCOVID-19 vaccination campaigns should be tailored for PLWH and incorporate stigma reduction interventions within healthcare settings.

Indexed as

COVID-19COVID-19 VaccinesHIV InfectionsPatient Acceptance of Health CareVaccinationAdultCross-Sectional StudiesFemaleHumansKazakhstanMaleMiddle AgedSARS-CoV-2Social StigmaCOVID-19 VaccinesanxietyattitudesCOVID-19health behaviorHIVstigmavaccine

Identifiers

PMID40170389
PMCPMC11963725

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.